Search Results
Found 1 results
510(k) Data Aggregation
(103 days)
Venus Velocity Diode Laser System
The Venus Velocity is intended for all Fitzpatrick skin types, including tanned skin, for use in dermatology, general and plastic surgery applications for:
- Hair removal;
- o Permanent hair reduction (defined as the long-term stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen); and
- . Treatment of pseudofolliculitis barbae.
The Venus Velocity consists of a console, a detachable diode laser applicator, and three interchangeable sapphire light quides/tips (small, medium, and large sizes). A water system and pump in the console distribute water to cool the handpiece and tips during device use, decreasing the likelihood of burns, discomfort, or pain during treatment. The system is also provided with a water filling kit.
The device incorporates several safety features, including an emergency laser stop button, user login and password protection, and other software and hardware settings to mitigate the risk of improper energy release and ensure that system outputs are within specifications. The device also comes with goggles and patient eye protectors.
This document is a 510(k) Summary for the Venus Velocity device. It describes the device's technical characteristics, intended use, and a summary of performance testing to demonstrate substantial equivalence to predicate devices. However, this document does not contain a detailed study proving the device meets acceptance criteria in the way typically expected for a clinical performance study. Instead, it relies on demonstrating that the device's technical specifications and safety profile are similar to existing, cleared devices.
Here's an analysis based on the provided text, addressing your points where information is available:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not provide a formal table of "acceptance criteria" for clinical performance. Instead, it implicitly defines acceptance by demonstrating that the device's technical parameters are within the ranges of predicate devices and that various safety and engineering tests passed.
Acceptance Criteria (Implicit) | Reported Device Performance |
---|---|
Technical Parameters (Wavelength, Spot Sizes, Pulse Durations, Fluence, Peak Power) | "The key energy parameters are very similar for the devices, where the available wavelength, spot sizes, pulse durations, fluence outputs, and peak power for the Venus Velocity are within the ranges previously cleared for the predicates." |
Maximum Frequency | "the higher frequency available with the Venus Velocity does not raise different questions of safety or effectiveness because other laser-based devices for similar indications have also been cleared with the same 10 Hz maximum frequency." |
Electromagnetic Compatibility (EMC) | "Electromagnetic compatibility and electrical safety testing was conducted per IEC 60601-1, IEC 60601-1-2, IEC 60601-2-22, and IEC 60825-1. All results were passing." |
Electrical Safety | "Electromagnetic compatibility and electrical safety testing was conducted per IEC 60601-1, IEC 60601-1-2, IEC 60601-2-22, and IEC 60825-1. All results were passing." |
Biocompatibility | "the patient-contacting materials are biocompatible per ISO 10993-1 and ISO 10993-5." |
Software Verification and Validation | "The Venus Velocity also underwent software verification and validation, with results demonstrating that the software is appropriate for release." |
System Verification Testing (Performance) | "System verification testing further confirmed that the system performs as intended, and that the energy outputs of the device meet specifications." |
2. Sample Size Used for the Test Set and Data Provenance
The document does not describe a clinical test set with human subjects. The "performance data" refers to engineering, safety, and software verification tests. Therefore, information about sample size, country of origin, or retrospective/prospective nature of a clinical test set is not provided.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not applicable as no clinical test set with ground truth established by experts is described in this document. The "tests" described are primarily engineering and technical validations against standards.
4. Adjudication Method for the Test Set
This information is not applicable as no clinical test set requiring expert adjudication is described in this document.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance
This information is not applicable. The Venus Velocity is a laser surgical instrument, not an AI-assisted diagnostic or interpretative device that would involve human readers or AI assistance in that context.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
This information is not applicable. The Venus Velocity is a physical medical device (laser system) and does not involve AI algorithms in the sense of a standalone diagnostic or interpretative tool.
7. The Type of Ground Truth Used
For the engineering and safety tests, the "ground truth" was adherence to established international standards (e.g., IEC 60601 series, ISO 10993 series) and the specified technical parameters of the device. For software, it was "demonstrating that the software is appropriate for release."
8. The Sample Size for the Training Set
This information is not applicable. The Venus Velocity is a physical medical device, not an AI/machine learning model that requires a training set of data.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable for the same reason as point 8.
In summary:
This 510(k) summary focuses on demonstrating "substantial equivalence" to legally marketed predicate devices through a comparison of technological characteristics, intended use, and by showing the device meets relevant engineering, electrical safety, biocompatibility, and software validation standards. It does not present a clinical study with human subjects to establish specific performance metrics like sensitivity, specificity, or permanent hair reduction rates against predefined acceptance criteria for a new clinical claim. Instead, the claim of "permanent hair reduction" is tied to the predicate devices and general understanding of "laser surgical instrument" performance, and the device's technical specifications are verified to be safe and effective within those established ranges.
Ask a specific question about this device
Page 1 of 1